Showing posts with label survivors. Show all posts
Showing posts with label survivors. Show all posts

Sunday, January 6, 2013

Declining Second Primary Ovarian Cancer After First Primary Breast Cancer.


Declining Second Primary Ovarian Cancer After First Primary Breast Cancer.


Jan 2013

Source

Sara J. Schonfeld, Amy Berrington de Gonzalez, Ruth M. Pfeiffer, and William F. Anderson, Department of Health and Human Services (DHHS), National Institutes of Health (NIH), National Cancer Institute, Bethesda; Kala Visvanathan, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.

Abstract


PURPOSE: Although ovarian cancer incidence rates have declined in the United States, less is known of ovarian cancer trends among survivors of breast cancer. Therefore, we examined second primary ovarian cancers after first primary breast cancer. 

METHODS: Data were obtained from the Surveillance, Epidemiology, and End Results program (1973 to 2008). Standardized incidence ratios (SIRs) were calculated as the observed numbers of ovarian cancers among survivors of breast cancercompared with the expected numbers in the general population. Absolute rates were measured as the incidence rates for second primary ovarian cancer by year of diagnosis of the first primary breast cancer adjusted for age of breast cancerdiagnosis and years since diagnosis.

RESULTS: SIRs for second primary ovarian cancer were elevated over the entire study period (SIR, 1.24; 95% CI, 1.2 to 1.3), whereas the absolute rates declined with an estimated annual percentage change near 1% (-1.34% to -0.09% per year). Secular trends for second ovarian cancers were similar after estrogen receptor (ER) -positive and ER-negative breast cancers, whereas the age-specific patterns varied significantly by ER expression (P for interaction < .001). The largest SIR was among w

CONCLUSION: Persistently elevated SIRs along with decreasing absolute rates over the entire study period suggest that ovarian cancers in both the general population and survivors of breast cancer are declining in parallel, possibly because of common risk factor exposures. Analytic studies are needed to further assess the parallel overall trends and the age-specific interaction by ER expression.

Full Text Article

Wednesday, October 24, 2012

Hopelessness and Complementary Therapy Use in Patients With Ovarian Cancer.


Hopelessness and Complementary Therapy Use in Patients With Ovarian Cancer.


Oct 2012

Source

Author Affiliations: Department of Nursing and Patient Care Services (Drs Gross and Fonteyn) and Medical Gynecologic Oncology (Dr Matulonis), Dana-Farber Cancer Institute; Harvard Medical School, Boston, Massachusetts; and College of Nursing and Health Sciences, University of Massachusetts, Boston (Drs Cromwell and Hayman).

Abstract


BACKGROUND: Hopelessness negatively affects ovarian cancer patients' quality of life (QOL). Research validating the effects of complementary and alternative medicine (CAM) use on QOL and hope is scarce, even though QOL and hope are reasons that patients cite for using CAM therapy. Clinicians need effective, evidence-based interventions to improve QOL and reduce hopelessness. 

OBJECTIVE:  The objectives of this study were to examine factors influencing hopelessness in patients with newly diagnosed disease, long-term survivors, and patients experiencing ovarian cancer recurrence and to examine the effects of CAM on hopelessness in the same population. 

METHODS:  Surveys of ovarian cancer patients (N = 219) undergoing treatment at a comprehensive cancer center in the United States were analyzed. Descriptive, correlation, and multivariate analyses described variables and demonstrated the effects of sociodemographics, disease state, psychological distress, QOL, CAM use, and faith on hopelessness. 

RESULTS:  Patients ages 65 years or older (-0.95, P = .03), with strong faith (-0.28, P = .00), and good QOL (0.11, P = .00) directly reduced hopelessness scores (mean, 3.37). Massage therapy substantially reduced hopelessness scores (-1.07, P = .02); holding age constant, employed patients were twice as likely to use massage (odds ratio, 2.09; P = .04). Patients who had newly diagnosed and recurrent ovarian cancer were more hopeless because of greater distress from symptoms and adverse effects of treatment. 

CONCLUSION:  Patients who used massage therapy were significantly less hopeless, as were those with strong faith and well-controlled disease symptoms and treatment for adverse effects.

IMPLICATIONS FOR PRACTICE: Support of spiritual needs and symptom management are important interventions to prevent and/or reduce hopelessness, especially for patients with newly diagnosed and recurrent ovarian cancer. Further research testing the positive effect of massage interventions on hopelessness is needed.